title: Ablation of atrial arrhythmias in heart failure.
abstract: HF and AF are on the rise and often coexist. Pharmacologic rhythm control has not been shown to improve outcomes compared with pharmacologic rate control. It is possible that the benefits of maintaining SR are offset by the adverse effects of AADs. Catheter ablation of AF offers an opportunity to achieve SR without the downside of AADs. Several studies have shown that AF ablation improves prognostic markers, including ventricular function, exercise tolerance, and perceived quality of life in HF patients. Studies addressing the impact of this treatment strategy on cardiovascular outcomes and cost-effectiveness are ongoing.
authors.affiliation: Albert Einstein College of Medicine, Montefiore Hospital, Bronx, NY, USA.
authors.forename: Philip
authors.initials: P
authors.lastname: Aagaard
authors.affiliation: Albert Einstein College of Medicine, Montefiore Hospital, Bronx, NY, USA; Texas Cardiac Arrhythmia Institute, St David's Medical Center, 3000 North I-35, Austin, TX 78705, USA; Department of Cardiology, University of Foggia, Foggia, Italy.
authors.forename: Luigi
authors.initials: L
authors.lastname: Di Biase
authors.affiliation: Texas Cardiac Arrhythmia Institute, St David's Medical Center, 3000 North I-35, Austin, TX 78705, USA; Department of Biomedical Engineering, University of Texas, Austin, TX, USA; Division of Cardiology, Stanford University, Stanford, CA, USA; Case Western Reserve University, Cleveland, OH, USA; EP Services, California Pacific Medical Center, San Francisco, CA, USA; Interventional Electrophysiology, Scripps Clinic, San Diego, CA, USA. Electronic address: dr.natale@gmail.com.
authors.forename: Andrea
authors.initials: A
authors.lastname: Natale
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D017115:Catheter Ablation / Q000379:methods*; D006329:Heart Conduction System / Q000187:drug effects / Q000473:pathology; D006333:Heart Failure / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000523:psychology; D006339:Heart Rate; D006801:Humans; D011788:Quality of Life; D013318:Stroke Volume; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents
keywords: Antiarrhythmic drugs; Atrial arrhythmia; Atrial fibrillation; Atrial fibrillation ablation; Heart failure; Rate control; Rhythm control